Mustafa Zanyar Akkuzu, Orhan Sezgin, Fehmi Ateş, O. Özdoğan, Serkan Yaraş, Ferzan Aydin, H. Balci, Enver Üçbilek, Engin Altıntaş
{"title":"Gastrointestinal Stent Uygulamaları: Tek merkez deneyimi","authors":"Mustafa Zanyar Akkuzu, Orhan Sezgin, Fehmi Ateş, O. Özdoğan, Serkan Yaraş, Ferzan Aydin, H. Balci, Enver Üçbilek, Engin Altıntaş","doi":"10.17944/MKUTFD.804229","DOIUrl":null,"url":null,"abstract":"Stent Applications: Single Objective: Gastrointestinal (GI) stents are used for palliative purposes in malignant or benign strictures in the gastrointestinal tract and pressure or fistulas associated with neighboring organ malignancies such as lung cancer, or stenosis or leakage after operations. In this study, we aimed to share our clinical experience with GI stents by evaluating the reasons and course of GI stents. Materials and Methods: Patients who had a GI stent in our clinic between 2014 and 2019 were included in the study. Retrospectively, the reason for stent insertion, the type of stent, the presence or absence of complications, the management of the complications and the life span of the patients were analyzed. Especially in advanced stage cancers, the effectiveness of stents in palliative treatment and their contribution to life span were evaluated. Results: During this period, a total of 36 patients had GI stents implanted. 24 (67%) of our patients were male and 12 (33%) were female. The mean age of men was 67 ± 13.8, and the mean age of women was 45.6 ± 11.5. Those who are stented for malign reasons; A stent was implanted for 44.5% esophageal cancer, 19.5% stomach cancer, 16.6% lung cancer and 5.5% rectal cancer. Of those who were stented for benign reasons, 11.1% had a fistula, and 2.8% had a stent due to stage d esophagitis. SEMS was attached to all of them. 27% of our patients were still alive. 73% of our patients died and when we looked at the average life span, we found it as 109.6 ± 101 days. Conclusion: As a result, it is seen that the use of stents in palliation of patients with inoperable digestive system stenosis is an effective method for a quality palliation in the short term. By using self-expanding metal stents, malignant and benign dysphagia can be alleviated.","PeriodicalId":30746,"journal":{"name":"Mustafa Kemal Universitesi Tip Dergisi","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mustafa Kemal Universitesi Tip Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17944/MKUTFD.804229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Stent Applications: Single Objective: Gastrointestinal (GI) stents are used for palliative purposes in malignant or benign strictures in the gastrointestinal tract and pressure or fistulas associated with neighboring organ malignancies such as lung cancer, or stenosis or leakage after operations. In this study, we aimed to share our clinical experience with GI stents by evaluating the reasons and course of GI stents. Materials and Methods: Patients who had a GI stent in our clinic between 2014 and 2019 were included in the study. Retrospectively, the reason for stent insertion, the type of stent, the presence or absence of complications, the management of the complications and the life span of the patients were analyzed. Especially in advanced stage cancers, the effectiveness of stents in palliative treatment and their contribution to life span were evaluated. Results: During this period, a total of 36 patients had GI stents implanted. 24 (67%) of our patients were male and 12 (33%) were female. The mean age of men was 67 ± 13.8, and the mean age of women was 45.6 ± 11.5. Those who are stented for malign reasons; A stent was implanted for 44.5% esophageal cancer, 19.5% stomach cancer, 16.6% lung cancer and 5.5% rectal cancer. Of those who were stented for benign reasons, 11.1% had a fistula, and 2.8% had a stent due to stage d esophagitis. SEMS was attached to all of them. 27% of our patients were still alive. 73% of our patients died and when we looked at the average life span, we found it as 109.6 ± 101 days. Conclusion: As a result, it is seen that the use of stents in palliation of patients with inoperable digestive system stenosis is an effective method for a quality palliation in the short term. By using self-expanding metal stents, malignant and benign dysphagia can be alleviated.